{"status":"success","data":{"title":"Seizures and Status Epilepticus","slug":"status-epilepticus","tags":["phenytoin","fosphenytoin","Midazolam","lorazepam","Propofol","Pentobarbital","Thiamine","Ceftriaxone","vancomycin","pyridoxine"],"collection":["Neurology","Critical Care"],"content":"<h1 id=\"seizures-and-status-epilepticus\">Seizures and Status Epilepticus</h1>\n<h2 id=\"generalized-convulsive-status-epilepticus-gcse-\">Generalized Convulsive Status Epilepticus (GCSE)</h2>\n<ul>\n<li>Continuous seizure activity ≥ 10 min, or at least 2 seizures without full recovery of consciousness between seizures <em>(VA Cooperative Trial on Treatment of GCSE)</em></li>\n</ul>\n<h2 id=\"mortality\">Mortality</h2>\n<p>10-40% for adults. If ≥ 60 minutes of ongoing sz activity, loss of compensatory mechanisms.</p>\n<h2 id=\"causes\">Causes</h2>\n<p>Most common in adults: Cerebrovascular disease</p>\n<p>Most common in pediatrics: Fever and infection</p>\n<p><strong>Infectious</strong></p>\n<ul>\n<li>Meningitis</li>\n<li>Encephalitis</li>\n<li>Brain abscess</li>\n</ul>\n<p><strong>Vascular</strong> </p>\n<ul>\n<li>Ischemic CVA</li>\n<li>SAH</li>\n<li>SDH</li>\n<li>EDH</li>\n<li>Vasculitis</li>\n</ul>\n<p><strong>Metabolic</strong></p>\n<ul>\n<li>Hyponatremia</li>\n<li>Hypoglycemia</li>\n<li>Hypocalcemia</li>\n<li>Hypomagnesemia</li>\n</ul>\n<p><strong>Toxic</strong></p>\n<ul>\n<li>Cocaine`</li>\n<li>Tricyclics</li>\n<li>Anticholinergics</li>\n<li>EtOH withdrawal</li>\n</ul>\n<p><strong>Tumors</strong></p>\n<p><strong>Eclampsia</strong></p>\n<p><strong>Recent change in medication</strong></p>\n<h2 id=\"workup\">WORKUP</h2>\n<p><strong>Labs:</strong></p>\n<ul>\n<li>Serum electrolytes, calcium, magnesium, glucose, BUN, Creatinine, LFT</li>\n<li>Antiepileptic drug levels, if appropriate</li>\n<li>Urine tox screen</li>\n<li>Consider: EtOH, Aspirin/Acetaminophen level, tricyclics tox screen</li>\n<li>Consider: LP procedure, if suspect CNS infection</li>\n<li>Note: A challenge is that GCSE can actually cause fevers and cause WBC in CSF</li>\n</ul>\n<p><strong>Imaging:</strong> Noncontrast head CT</p>\n<p><strong>EEG:</strong> Not indicated in the ED, however: <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9701373\">(DeLorenzo RJ et al, Epilepsia 1998)</a></p>\n<ul>\n<li>Useful to help assess subtle GCSE after persistent comatose state after termination of apparent sz, or when paralytics or heavy sedation medications used (masks sz activity)</li>\n<li>48% of patients continued to have subtle sz on EEG monitoring in first 24 hrs despite no signs of ongoing convulsions.</li>\n</ul>\n<h2 id=\"management\">Management</h2>\n<ol>\n<li>Secure airway and establish IV access</li>\n<li>Bedside glucose check. Treat if glucose &lt; 80 mg/dL or unable to determine.</li>\n<li>Benzodiazepine: <strong><span class=\"drug\">Diazepam</span></strong> and <strong><span class=\"drug\">lorazepam</span></strong> equally effective in stopping sz. Because of <span class=\"drug\">lorazepam’s</span> smaller volume of distribution, CNS levels remain more constant over longer period.</li>\n<li><p><strong><span class=\"drug\">Phenytoin</span> / <span class=\"drug\">fosphenytoin</span></strong>: Dose 20 mg <strong><span class=\"drug\">Phenytoin</span></strong> max rate of infusion = 50 mg/min, because of hypotension from propylene glycol diluent. Need large bore IV because of caustic ph of 12.</p>\n<ul>\n<li><strong><span class=\"drug\">Fosphenytoin</span></strong> max rate of infusion = 150 mg/min (more neutral pH 9). Conversion to phenytoin half-life = 8-15 minutes.</li>\n</ul>\n</li>\n<li><p>Consider <strong><span class=\"drug\">pyridoxine</span></strong> (B6) for possible INH toxicity (5 g IV over 3-5 minutes)</p>\n</li>\n<li><strong><span class=\"drug\">Thiamine</span></strong> 100 mg IV — if malnourished or chronic EtOH abuse history</li>\n<li><strong><span class=\"drug\">Ceftriaxone</span></strong> 2 g IV and <strong><span class=\"drug\">vancomycin</span></strong> 1 g IV — if suspect CNS infection</li>\n</ol>\n<p>If refractory above treatment, consider any of following:</p>\n<ul>\n<li><strong><span class=\"drug\">Midazolam</span></strong>: 0.2 mg/kg bolus, 0.05-2 mg/kg/hr infusion</li>\n<li><strong><span class=\"drug\">Propofol</span>:</strong> 3-5 mg/kg bolus, 1-15 mg/kg/hr infusion. Risk: hypotension, lipidemia, metabolic acidosis</li>\n<li><strong><span class=\"drug\">Pentobarbital</span>:</strong> 5-15 mg/kg load over 1 hour, then 0.5-10 mg/kg/hr infusion. Risk of hypotension.</li>\n</ul>\n<!-- -->\n<h2 id=\"medication-algorithm-summary-for-status-epileptics\">Medication Algorithm Summary for Status Epileptics</h2>\n<p><img src=\"https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/38518f42-051d-5f04-a720-523b41da3b4a/640.png\" alt=\"\"></p>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/9701373\">DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, Brown A, Garnett L.Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998 Aug;39(8):833-40.</a></li>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=Generalized+convulsive+status+epilepticus+in+adults+and+children%3A+treatment+guidelines+and+protocols.\">Shearer P, Riviello J.Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. EM Clinics of NA. 2011, 29:51-64</a></li>\n</ul>\n"}}